TABLE OF CONTENTS
Volume 153, Issue 8 (April 2008)
View table of contents by subject categoryCommentary
Commentary
Lipoic acid supplementation and endothelial function FREE
J-C Tardif and E Rhéaume
Br J Pharmacol 153: 1587-1588; advance online publication, March 17, 2008; doi:10.1038/bjp.2008.74
See also: Research Paper by Smith et al.Reviews
Review Article
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents
G Heusch
Br J Pharmacol 153: 1589-1601; advance online publication, January 28, 2008; doi:10.1038/sj.bjp.0707673
Asthma from a pharmacogenomic point of view
C Szalai, I Ungvári, L Pelyhe, G Tölgyesi and A Falus
Br J Pharmacol 153: 1602-1614; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.55
Research Papers
Cardiovascular and pulmonary pharmacology
Lipoic acid significantly restores, in rats, the age-related decline in vasomotion
A R Smith, F Visioli, B Frei and T M Hagen
Br J Pharmacol 153: 1615-1622; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.28
See also: Commentary by Tardif & RhéaumeThe antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways
M Iwasaki, Y Hayashi, T Kamibayashi, A Yamatodani and T Mashimo
Br J Pharmacol 153: 1623-1630; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.35
Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse
D Sodini, B Baragatti, S Barogi, V E Laubach and F Coceani
Br J Pharmacol 153: 1631-1640; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.36
Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin
H Shao, J Li, Y Zhou, Z Ge, J Fan, Z Shao and Y Zeng
Br J Pharmacol 153: 1641-1649; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.45
Gastrointestinal pharmacology
Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction
T D Barrett, W Yan, J M Freedman, G J Lagaud, J G Breitenbucher and N P Shankley
Br J Pharmacol 153: 1650-1658; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.44
Genitourinary, renal and endocrine pharmacology
Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces 
3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity
F Z T Mónica, A A O Bricola, F R Báu, L L Lopes Freitas, S A Teixeira, M N Muscará, F M F Abdalla, C S Porto, G De Nucci, A Zanesco and E Antunes
Br J Pharmacol 153: 1659-1668; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.39
Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice
M H Mooney, S Fogarty, C Stevenson, A M Gallagher, P Palit, S A Hawley, D G Hardie, G D Coxon, R D Waigh, R J Tate, A L Harvey and B L Furman
Br J Pharmacol 153: 1669-1677; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.37
Immunopharmacology and inflammation
Sodium/hydrogen exchange inhibition with cariporide reduces leukocyte adhesion via P-selectin suppression during inflammation
U Buerke, D Pruefer, J M Carter, M Russ, A Schlitt, R Prondzinsky, J Makowski, S Rohrbach, B Niemann, C Schulze, M Dahm, C-F Vahl, K Werdan and M Buerke
Br J Pharmacol 153: 1678-1685; advance online publication, March 10, 2008; doi:10.1038/sj.bjp.0707647
Molecular and cellular mechanisms
Antimalarial drugs inhibit human 5-HT3 and GABAA but not GABAC receptors BJPOpen
A J Thompson and S C R Lummis
Br J Pharmacol 153: 1686-1696; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.34
9-Phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels
T Grand, M Demion, C Norez, Y Mettey, P Launay, F Becq, P Bois and R Guinamard
Br J Pharmacol 153: 1697-1705; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.38
A nitric oxide/Ca2+/calmodulin/ERK1/2 mitogen-activated protein kinase pathway is involved in the mitogenic effect of IL-1 in human astrocytoma cells
A Meini, C Sticozzi, L Massai and M Palmi
Br J Pharmacol 153: 1706-1717; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.40
Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic -cell line, BRIN-BD11
S Dhayal, H J Welters and N G Morgan
Br J Pharmacol 153: 1718-1727; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.43
Neuropharmacology
Cardiovascular effects of activation of central 
7 and 42 nAChRs: a role for vasopressin in anaesthetized rats
C Moore, Y Wang and A G Ramage
Br J Pharmacol 153: 1728-1738; advance online publication, February 25, 2008; doi:10.1038/bjp.2008.47
Thymol and related alkyl phenols activate the hTRPA1 channel
S P Lee, M T Buber, Q Yang, R Cerne, R Y Cortés, D G Sprous and R W Bryant
Br J Pharmacol 153: 1739-1749; advance online publication, March 10, 2008; doi:10.1038/bjp.2008.85
Pharmacokinetics, drug metabolism, toxicology
Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats
M R Santos, M J Rodríguez-Gómez, G C Justino, N Charro, M H Florencio and L Mira
Br J Pharmacol 153: 1750-1761; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.46
Corrigenda
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats FREE
D R H Huntjens, A Strougo, A Chain, A Metcalf, S Summerfield, D J M Spalding, M Danhof and O Della Pasqua
Br J Pharmacol 153: 1762; doi:10.1038/bjp.2008.105
Antagonism of thromboxane receptors by diclofenac and lumiracoxib FREE
E Selg, C Buccellati, M Andersson, G E Rovati, M Ezinga, A Sala, A-K Larsson, E Ambrosio, L Låstbom, V Capra, B Dahlén, Å Ryrfeldt, G C Folco and S-E Dahlén
Br J Pharmacol 153: 1763; doi:10.1038/bjp.2008.106
Errata
Sildenafil reduces the alcohol-induced gastric damage: just say 'NO' FREE
R Duffin, C A Shaw and A G Rossi
Br J Pharmacol 153: 1764; doi:10.1038/bjp.2008.103
-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?
